Schwartz L - Search Results

1

Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma.

Vuky J, Yu R, Schwartz L, Motzer RJ. Vuky J, et al. Among authors: schwartz l. Invest New Drugs. 2002 Aug;20(3):327-30. doi: 10.1023/a:1016270206374. Invest New Drugs. 2002. PMID: 12201495 Clinical Trial.

2

Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.

Motzer RJ, Bajorin DF, Schwartz LH, Hutter HS, Bosl GJ, Scher HI, Lyn P, Fischer P. Motzer RJ, et al. Among authors: schwartz lh. J Clin Oncol. 1994 Nov;12(11):2277-83. doi: 10.1200/JCO.1994.12.11.2277. J Clin Oncol. 1994. PMID: 7525885 Clinical Trial.

3

Paclitaxel in germ cell cancer.

Motzer RJ, Chou TC, Schwartz L, Bosl GJ, Bajorin DF, Hutter H. Motzer RJ, et al. Among authors: schwartz l. Semin Oncol. 1995 Jun;22(3 Suppl 6):12-5. Semin Oncol. 1995. PMID: 7597428 Review.

4

Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.

Motzer RJ, Schwartz L, Law TM, Murphy BA, Hoffman AD, Albino AP, Vlamis V, Nanus DM. Motzer RJ, et al. Among authors: schwartz l. J Clin Oncol. 1995 Aug;13(8):1950-7. doi: 10.1200/JCO.1995.13.8.1950. J Clin Oncol. 1995. PMID: 7636535 Clinical Trial.

5

A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma.

Berg WJ, Schwartz LH, Amsterdam A, Mazumdar M, Vlamis V, Law TM, Nanus DM, Motzer RJ. Berg WJ, et al. Among authors: schwartz lh. Invest New Drugs. 1997;15(4):353-5. doi: 10.1023/a:1005902022076. Invest New Drugs. 1997. PMID: 9547678 Clinical Trial.

6

Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.

Motzer RJ, Rakhit A, Schwartz LH, Olencki T, Malone TM, Sandstrom K, Nadeau R, Parmar H, Bukowski R. Motzer RJ, et al. Among authors: schwartz lh. Clin Cancer Res. 1998 May;4(5):1183-91. Clin Cancer Res. 1998. PMID: 9607576 Clinical Trial.

7

A phase II study of pyrazoloacridine in patients with advanced renal cell carcinoma.

Berg WJ, McCaffrey J, Schwartz LH, Mariani T, Mazumdar M, Motzer RJ. Berg WJ, et al. Among authors: schwartz lh. Invest New Drugs. 1998-1999;16(4):337-40. doi: 10.1023/a:1006143008040. Invest New Drugs. 1998. PMID: 10426668

8

Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.

Motzer RJ, Murphy BA, Bacik J, Schwartz LH, Nanus DM, Mariani T, Loehrer P, Wilding G, Fairclough DL, Cella D, Mazumdar M. Motzer RJ, et al. Among authors: schwartz lh. J Clin Oncol. 2000 Aug;18(16):2972-80. doi: 10.1200/JCO.2000.18.16.2972. J Clin Oncol. 2000. PMID: 10944130 Clinical Trial.

9

Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.

Kemeny N, Gonen M, Sullivan D, Schwartz L, Benedetti F, Saltz L, Stockman J, Fong Y, Jarnagin W, Bertino J, Tong W, Paty P. Kemeny N, et al. Among authors: schwartz l. J Clin Oncol. 2001 May 15;19(10):2687-95. doi: 10.1200/JCO.2001.19.10.2687. J Clin Oncol. 2001. PMID: 11352961 Clinical Trial.

10

Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma.

Motzer RJ, Rakhit A, Thompson JA, Nemunaitis J, Murphy BA, Ellerhorst J, Schwartz LH, Berg WJ, Bukowski RM. Motzer RJ, et al. Among authors: schwartz lh. J Interferon Cytokine Res. 2001 Apr;21(4):257-63. doi: 10.1089/107999001750169934. J Interferon Cytokine Res. 2001. PMID: 11359657 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,618 results

Search Page

Filters